These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7911356)

  • 21. Audit of peripheral stem cell transplantation for aplastic anemia in multitransfused infected patients.
    Seth T; Kanga U; Sood P; Sharma V; Mishra P; Mahapatra M
    Transplant Proc; 2012 May; 44(4):922-4. PubMed ID: 22564586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia.
    Al-Zahrani H; Nassar A; Al-Mohareb F; Al-Sharif F; Mohamed S; Al-Anazi K; Patel M; Rasheed W; Saleh AJ; Bakr M; Ahmed S; Ibrahim K; Hussain F; Elkum N; Elhassan T; Nurgat Z; Chaudhri N; Aljurf M
    Biol Blood Marrow Transplant; 2011 May; 17(5):717-22. PubMed ID: 20736079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful bone marrow transplantation in sensitized aplastic anemia patients using total lymphoid irradiation for conditioning: long-term follow-up.
    Zapatero A; Marín A; López M; Martín De Vidales C; Cerezo L; Domínguez P; Pérez Torrubia A
    Hematol Oncol; 1996 Dec; 14(4):165-72. PubMed ID: 9267462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
    Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
    Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow transplantation for severe aplastic anemia in children: conditioning with cyclophosphamide and total lymphoid irradiation.
    Lin KH; Lui LT; Lin DT; Lin KS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(1):1-6. PubMed ID: 2637581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
    van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
    Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.
    Arranz R; Conde E; Rodriguez-Salvanés F; Pajuelo FJ; Cabrera R; Sanz MA; Petit J; Bueno J; Maldonado J; Odriozola J; Conde JG; Brunet S; Carreras E; Iriondo A; Fernández-Rañada JM; Marín P;
    Bone Marrow Transplant; 2002 Feb; 29(3):205-11. PubMed ID: 11859392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
    Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L
    Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
    Kang HJ; Shin HY; Choi HS; Ahn HS
    Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Second allogenic bone marrow transplantation after late graft rejection in a patient with severe aplastic anemia].
    Stamatović D; Balint B; Todorić-Zivanović B; Marjanović S; Lakić-Trajković Z; Malesević M
    Vojnosanit Pregl; 2000; 57(5):95-8. PubMed ID: 11213682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone marrow transplantation for Fanconi's anaemia: the Hammersmith experience 1977-89.
    Hows JM; Chapple M; Marsh JC; Durrant S; Yin JL; Swirsky D; Gordon-Smith EC
    Bone Marrow Transplant; 1989 Nov; 4(6):629-34. PubMed ID: 2684308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors.
    Kiem HP; McDonald GB; Myerson D; Spurgeon CL; Deeg HJ; Sanders JE; Doney K; Appelbaum FR; Sullivan KM; Witherspoon RP; Storb R
    Biol Blood Marrow Transplant; 1996 May; 2(2):93-9. PubMed ID: 9118304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors.
    Tzeng CH; Chen PM; Fan S; Liu JH; Chiou TJ; Hsieh RK
    Bone Marrow Transplant; 1996 Aug; 18(2):273-7. PubMed ID: 8864434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms.
    Sullivan KM; Storb R; Buckner CD; Fefer A; Fisher L; Weiden PL; Witherspoon RP; Appelbaum FR; Banaji M; Hansen J
    N Engl J Med; 1989 Mar; 320(13):828-34. PubMed ID: 2648143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bone marrow transplantation in aplastic anemia. Experience at a Mexican institution. Bone marrow transplantation group of the Salvador Zubirán National Institute of Nutrition].
    León-Rodríguez E; Sosa Sánchez R; Gómez E; Ochoa Sosa C
    Rev Invest Clin; 1993; 45(6):559-64. PubMed ID: 8159876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.